Matica Biotechnology: Leading the Charge in Cell & Gene Therapy Manufacturing for 2025 Matica Biotechnology has become a leading CDMO for cell and gene therapies in 2025, achieving significant growth and client trust in the industry.

Matica Biotechnology: Leading the Charge in Cell & Gene Therapy Manufacturing for 2025 #USA #gene_therapy #Cell_Therapy #College_Station #Matica_Biotechnology

Strategic Collaboration Between Matica Biotechnology and Texas A&M's NCTM to Transform Cell and Gene Therapy Landscape Matica Biotechnology joins forces with NCTM to create a complete support framework for cell and gene therapy innovators, enhancing efficiency and reducing costs.

Strategic Collaboration Between Matica Biotechnology and Texas A&M's NCTM to Transform Cell and Gene Therapy Landscape #United_States #College_Station #Matica_Biotechnology #NCTM #Cell_and_Gene_Therapy